Kuros Biosciences Competitors and Similar CompaniesClear all

Merus's competitors and similar companies include Dermavant Sciences and Sorrento Therapeutics.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Dermavant Sciences
Dermavant Sciences
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founding Date
Founding Date
2003
Founding Date
2016
Founding Date
2006
Type
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Utrecht, NL HQ
Cambridge, US
Locations
Long Beach, US HQ
Basel, CH
Durham, US
Morrisville, US
New York, US
Phoenix, US
Locations
San Diego, US HQ
San Diego, US
Employees
Employees
260
Employees
2228% decrease
Employees
31019% decrease
Valuation ($)
Valuation ($)
3.6 b
Valuation ($)
N/A
Valuation ($)
1.5 m

Financial

Revenue (est.)
Revenue (est.)
$36.1m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
$62.8m (FY, 2022)
Net income
Net income
($215.3m) (FY, 2024)
Net income
($255.3m) (FY, 2019)
Net income
($577.8m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 149.3m
Total funding raised
$ 200m
Total funding raised
$ 42.6m
For sources of this data, please see the company profile

View Company Profiles

Dermavant Sciences
HQ
Long Beach, US

Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company